byiShook Opinion
Dec 9, 2024 - 13:45
Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, mitapivat. The post Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug appeared first on Investor's Business Daily.
Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, mitapivat.
The post Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug appeared first on Investor's Business Daily.